A Study to Evaluate the Efficacy and Safety of Everolimus in Patients With Teratment-refractory Vascular Anomalies

Clinical trial NCT07477548 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07477548
Sponsor: Yonsei University
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Vascular Malformations Arteriovenous Malformations Venous Malformation Lymphangioma Nevus, Port-Wine Hemangioendothelioma Hemangioma

Start date: 2026-04-01
Primary completion: 2030-10-31
Enrollment: 67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.